INS and Alzheimer disease: Furthermore, ex vivo insulin stimulation activated the canonical signaling pathways significantly less in post-mortem brain sections of AD patients as compared to those of healthy subjects, suggesting the presence of central insulin resistance in AD (Talbot et al., 2012).